TCL Archive Seer Places Survival Now at Least At 45 Percent, Could Be As High As 50 Percent For 1973-79 Patients December 4, 1981
TCL Archive Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting August 29, 2003
TCL Archive Drug Approvals: FDA Approves Vectibix in mCRC With KRAS Companion Diagnostic May 30, 2014
TCL Archive FDA Grants Approvals to Lynparza, Blincyto, Xgeva, Gardasil 9 and Cyramza December 26, 2014